Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria L Bae-Jump

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 11, 2022
Adverse Urinary System Diagnoses among Older Women with Endometrial CancerChelsea Anderson, Andrew F Olshan, Jihye Park, et al.
Gynecologic Oncology|April 1, 2014
Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancerLiza Makowski, Chunxiao Zhou, Yan Zhong, et al.
Targeted Oncology|May 19, 2016
Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell LinesWeiya Z Wysham, Dario R Roque, Jianjun Han, et al.
Gynecologic Oncology|June 24, 2023
Gastrointestinal outcomes among older women with endometrial cancerChelsea Anderson, Anne F Peery, Victoria L Bae-Jump, et al.
Plos One|February 15, 2013
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cellsChunxiao Zhou, Tara A Steplowski, Hallum K Dickens, et al.
Cancer Medicine|November 25, 2014
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancerKevin M Schuler, Brooke S Rambally, Megan J DiFurio, et al.
JAMA Network Open|March 27, 2026
Diagnostic Timing and Ovarian Cancer SurvivalSarah E Soppe, Tzy-Mey Kuo, Victoria L Bae-Jump, et al.
Journal of Translational Medicine|August 22, 2014
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cellsJiandong Wang, Xiaoli Ma, Hannah M Jones, et al.
Cancer Causes & Control : CCC|January 4, 2024
Lymphedema self-assessment among endometrial cancer survivorsJordyn A Brown, Andrew F Olshan, Victoria L Bae-Jump, et al.
Environmental Health : a Global Access Science Source|December 15, 2023
Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell linesBrittany P Rickard, Marta Overchuk, Justin Tulino, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 11, 2022
Adverse Urinary System Diagnoses among Older Women with Endometrial CancerChelsea Anderson, Andrew F Olshan, Jihye Park, et al.
Gynecologic Oncology|April 1, 2014
Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancerLiza Makowski, Chunxiao Zhou, Yan Zhong, et al.
Targeted Oncology|May 19, 2016
Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell LinesWeiya Z Wysham, Dario R Roque, Jianjun Han, et al.
Gynecologic Oncology|June 24, 2023
Gastrointestinal outcomes among older women with endometrial cancerChelsea Anderson, Anne F Peery, Victoria L Bae-Jump, et al.
Plos One|February 15, 2013
Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cellsChunxiao Zhou, Tara A Steplowski, Hallum K Dickens, et al.
Cancer Medicine|November 25, 2014
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancerKevin M Schuler, Brooke S Rambally, Megan J DiFurio, et al.
JAMA Network Open|March 27, 2026
Diagnostic Timing and Ovarian Cancer SurvivalSarah E Soppe, Tzy-Mey Kuo, Victoria L Bae-Jump, et al.
Journal of Translational Medicine|August 22, 2014
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cellsJiandong Wang, Xiaoli Ma, Hannah M Jones, et al.
Cancer Causes & Control : CCC|January 4, 2024
Lymphedema self-assessment among endometrial cancer survivorsJordyn A Brown, Andrew F Olshan, Victoria L Bae-Jump, et al.
Environmental Health : a Global Access Science Source|December 15, 2023
Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell linesBrittany P Rickard, Marta Overchuk, Justin Tulino, et al.
Pageof 10